您要查找的是不是：
- Objective To observe the clinical effect of plasma-exchange therapy(PET) for chronic severe hepatitis B(CSH-B) and its influential factors. 目的观察血浆置换治疗慢性乙型重型肝炎的临床效果及其影响因素。
- Objective To observe the clinical effect of plasma-exchange therapy (PET) for chronic severe hepatitis B (CSH-B) and its influential factors. 摘要目的观察血浆置换治疗慢性乙型重型肝炎的临床效果及其影响因素。
- Methods:The amount of HBV DNA in the sera of patients with chronic hepatitis B (CHB), chronic severe hepatitis B (CSHB) and hepatic B cirrhosis (HBC) were measured with FQ PCR. 方法 :采用荧光定量 PCR( FQ- PCR)法检测慢性乙型肝炎 ( CHB)、慢性乙型重型肝炎 ( CSHB)、乙型肝炎性肝硬化 ( HBC)患者血清 HBV DNA含量。
- Clinical research on treatment on (68 cse of) chronic severe hepatitis B with plasmapheresis 血浆置换治疗慢性乙型重症肝炎68例临床体会
- The influence of plasma exchange on the serum level of AFP in patients with chronic severe hepatitis B 血浆置换治疗对慢性乙型重型肝炎患者血清甲胎蛋白水平的影响
- chronic severe hepatitis B 慢性乙型重型肝炎
- The RBC,Hb,PLC and PCT were lower in patients with chronic hepatitis B of severe degree and with chronic severe hepatitis B than in control ( p <0.01),while MCV,RDW,MPV and PDW higher in the two patient groups than in control( p <0.01); 两组病例组RBC、Hb、PLC、PCT值均显著低于健康对照组 (p <0 .;0 1);而MCV、PLC、PCT值均显著低于慢性重型肝炎组;MCV、RDW、MPV值均显著高于慢性重型肝炎组 (p <0
- Results: sTC concentrations were closely correlated with the Ishak score(P<0.01,r=-0.56) in the patients with chronic hepatitis B and severe hepatitis. 结果 :sTC水平与慢性乙肝及重型肝炎患者肝组织病变程度Ishak计分呈明显负相关 (P <0 0 1;r =-0 5 6)。
- Results When chronic hepatitis B patients were superinfected by HEV, the incidence rate of hepatitis gravis and severe hepatitis was higher. 结果经临床观察、对照和分析，发现重叠HEV感染的慢性乙肝患者的重型肝炎发生率和慢性乙肝重度发生率高。
- Objective To survey the mutuality of chronic severe hepatitis on peripheral blood cell and its results. 目的通过对慢性重型肝炎患者的外周血象分析,观察慢性重型肝炎的外周血象与其预后的相关性。
- Objective To study the effectiveness and safety of EPL in the treatment of chronic severe hepatitis, chronic hepatitis and fatty liver. 目的 应用易善力注射液治疗慢性重型肝炎、慢性肝炎和脂肪肝 ,进一步评价其安全性和疗效。
- Aim To observe the clinical therapeutic effects and adverse reaction of Lipo-PGE1 in treament of chronic severe hepatitis. 目的 观察前列腺素E1脂微球载体制剂 (凯时 ,Lipo PGE1)对慢性重症肝炎的治疗作用和副作用。
- Objective To analysis the inconsistent reason of clinical diagnosis and pathology diagnosis of chronic severe hepatitis (CSH). 摘要目的分析慢性重型肝炎(CSH)临床与病理诊断不相一致的原因。
- Results In liver disease group, the levels of PLD in patients with chronic hepatitis, chronic severe hepatitis and liver cirrhosis were sta... 05或0。01),且以肝硬变升高幅度最为显著。结论PLD活性测定是一项反映慢肝病患者肝脏纤维化的良好指标之一。
- Objective To evaluate the treatment of plasma exchange (PE) in patients with chronic severe hepatitis based on prothrombin activity (PTA). 摘要目的探讨根据凝血酶原活动度(PTA)预测重型肝炎高胆红素血症行血浆置换的临床疗效。
- Cai CJ, Lu MQ, Chong YT, et al.An evaluation of the prognosis of patients with chronic severe hepatitis using a model for end-stage liver disease. 蔡常洁，陆敏强，崇雨田，等.;应用终末期肝病模型对慢性重型肝炎患者的预后评估
- Objective: To evaluate the clinical efficiency of colon dialysis therapy with traditional Chinese and western medicine on chronic severe hepatitis. 摘要目的：观察中西医结合结肠透析疗法对慢性重型肝炎的临床疗效。
- Objective To study the complication of artificial liver support system(ALSS) on treating patients with chronic severe hepatitis. 目的 探讨人工肝支持系统（ALSS）治疗慢性重型肝炎时并发症的发生及其防治措施。
- Conclusion: Clinical manifestations of chronic severe hepatitis with idiopathic peritonitis are not representative and various. 结论：慢性重型肝炎合并原发性腹膜炎临床表现不典型、多样性。
- Objective To analysis the inconsistent reason of clinical diagnosis and pathology diagnosis of chronic severe hepatitis(CSH). 目的分析慢性重型肝炎(CSH)临床与病理诊断不相一致的原因。
